NExTNet vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionNExTNetIsomorphic Labs
PricingFreemiumContact for pricing
Target AudienceResearchers & biotech professionalsPharma companies & large drug development programs
Core OfferingAI-powered research platform with connected knowledge mapsAI-driven drug design engine for pharma partnerships
Technology BaseSemantic web & AI CopilotAlphaFold & proprietary predictive/generative models
Key IntegrationsChEMBL, PubMed, Ensembl, Google ScholarNot specified (pharma partnerships instead)
Latest News2026-06-17: NetNewsWire RSS discussion (unrelated)2026-05-12: Series B funding; Jan 2026: J&J collaboration

If you are an individual researcher or small team needing a ready-to-use tool for literature mining and hypothesis generation, NExTNet's freemium model and integrated semantic search are ideal. For pharma companies pursuing large-scale drug development through deep AI partnerships, Isomorphic Labs' AlphaFold-powered engine and recent Series B funding reflect proven enterprise capability, albeit with high upfront commitment.

NExTNet
NExTNet

NExTNet pairs evidence-backed Copilot answers with Explorer's connected knowledge maps for life sciences research.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Freemium
Contact Sales
Plans
$0/mo
$20/mo billed annually, $25/mo billed monthly
$50/mo billed annually, $62.50/mo billed monthly
$200/mo billed annually, $250/mo billed monthly
Custom
—
Popularity
6 views
7.5k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
—
Categories
🔬 Research & Education🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Evidence-backed Copilot answers linked to excerpts from verified scientific sources
Explorer connected search engine with interactive brainstorming maps of biomedical entities
List view for browsing genes, drugs, targets, pathways, and diseases with detailed properties
Semantic web unifying ChEMBL, PubMed, Google Scholar, and Ensembl
Nextnet Reader for open-access articles with tiered monthly limits
Copilot voice mode with metered monthly message quotas
Copilot advanced reasoning mode for deeper multi-step analysis
File uploads for document analysis and question answering
AI podcast generation from research content with monthly minute caps
Shareable team spaces, collections, and comments
Bring-your-own-data integrations on Starter and above
Session history retention from 14 days up to unlimited, by tier
Premium publisher paywall content available pay-per-piece on paid tiers
Premium reagent data access with monthly limits and add-on fees
Nextnet Notebooks for research notes and knowledge management (coming soon)
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO
Integrations
PubMed
Google Scholar
ChEMBL
Ensembl

What real users say: NExTNet vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

NExTNet

21 mentions across 4 sources · 51% positive — mixed (averaged across 4 sources)

YouTube, Product Hunt, Bluesky, GitHub

What users praise

  • • Easy to get started with a free plan.
  • • Visual knowledge graphs for exploring life sciences topics.
  • • Integrates data from ChEMBL, PubMed, Ensembl, Google Scholar.
  • • Designed specifically for life science researchers.

What frustrates them

  • • Almost no real user feedback to validate claims.
  • • Product Hunt launch received zero upvotes.
  • • Brand confusion with other 'nextnet' projects.
  • • Free plan has limited usage and features.

Researched Jul 5, 2026

Isomorphic Labs

No verifiable community signal. We scanned public discussion on Oct 7, 2026 and found posts matching the name “Isomorphic Labs”, but could not establish that they are about this product rather than something else sharing its name. Rather than publish a score built on the wrong subject, we publish none.

Who should pick which

  • Academic researcher investigating gene-disease links
    Pick: NExTNet

    NExTNet's freemium access and integration with PubMed, Ensembl, and Google Scholar allow for cost-effective literature mining and connection mapping.

  • Pharma company targeting a novel protein for drug design
    Pick: Isomorphic Labs

    Isomorphic Labs' AlphaFold-based Drug Design Engine and partnership model are tailored for large-scale predictive modeling and lead optimization.

  • Biotech startup needing collaborative discovery
    Pick: NExTNet

    NExTNet's sharing and collaboration features, plus its affordable pricing, suit small teams exploring early drug targets.

  • Large pharma organization seeking digital biology at scale
    Pick: Isomorphic Labs

    Isomorphic's Series B funding and J&J collaboration validate its capability for multi-billion-dollar pipeline acceleration.

Frequently Asked Questions

NExTNet vs Isomorphic Labs: which should you choose?

If you are an individual researcher or small team needing a ready-to-use tool for literature mining and hypothesis generation, NExTNet's freemium model and integrated semantic search are ideal. For pharma companies pursuing large-scale drug development through deep AI partnerships, Isomorphic Labs' AlphaFold-powered engine and recent Series B funding reflect proven enterprise capability, albeit with high upfront commitment.

Can I use Isomorphic Labs as an individual researcher?

No, Isomorphic Labs only partners with pharma companies and large drug development programs; individuals should use NExTNet.

Does NExTNet integrate with drug databases like ChEMBL?

Yes, NExTNet integrates ChEMBL, PubMed, Ensembl, and Google Scholar for evidence-backed answers.

Is Isomorphic Labs based on AlphaFold?

Yes, it builds on the Nobel Prize-winning AlphaFold system for protein structure prediction.

What is the pricing for NExTNet?

Freemium; basic features free, Pro Plus for unlimited usage.

Has Isomorphic Labs raised recent funding?

Yes, a $600M external investment round in March 2025, and a Series B in February 2026.

Does NExTNet allow sharing discoveries?

Yes, it supports collaboration via maps and lists.

What drug targets did Isomorphic Labs work on with J&J?

The collaboration (announced Jan 2026) focuses on AI-driven drug discovery, but specific targets are not disclosed.

Is NExTNet suitable for non-biomedical research?

No, it is focused on life sciences and may not cover other domains.

More NExTNet or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026